Dr. Lin's clinical interests involve providing care to hospitalized patients and assisting in the training of new physicians. He provides a high level of quality, compassionate medical care to all patients.
M.D., UCLA School of Medicine, Los Angeles, California, 2004
B.A., Occidental College, Los Angeles, California, 1998
University of California, Davis, Sacramento, CA, 2004
American Board of Internal Medicine, 2007
American College of Physicians
Society of Hospital Medicine
Select Recent Publications
Lin HM, Teitell MA. Second Malignancy after Treatment of Pediatric Hodgkin Disease. J Ped Hem/Onc. 2005 Jan 27(1):28-36.
Puri A, Rawat SS, Lin HM, Finnegan CM, Mikovits J, Ruscetti FW, Blumenthal R. An Inhibitor of Glycosphingolipid Metabolism Blocks HIV-1 Infection of Primary T-cells. AIDS. 2004 Apr 9; 18(6):849-58.
Lin HM. Coenzyme Q10 as a Treatment for Heart Disease. Nutrition Bytes 2001. 7(2) Article 1
Hug P, Lin HM, Korte T, Xiao X, Dimitrov DS, Wang JM, Puri A, Blumenthal R. Glycosphingolipids promote entry of a broad range of human immunOdeficiency virus type 1 isolates into cell lines expressing CD4. CXCR4. and/or CCR5. J Virol. 2000 Jul; 74(14):6377-85.
Martin GG, Lin HM, Luc C. Reexamination of hemocytes in brine shrimp (Crustacea. branchiopoda). J Morphol. 1999 Dec; 242(3):283-94.